All we need is result from burns phase 1/2 to come back indicating it met all endpoints and showed a significant improvement in wound closing and infection reduction. Best possible scenario would be the testing hospital is so impressed they request emergency access to allow use on current difficult to treat wounds that are not responding to other treatments. Now that will be a good day. Fingers crossed.
If the product is proven to work surely these previously mentioned big pharma companies (plural I hope) would be tripping over each other to get hold of the tech.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |